Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque Rupture

Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the involvement of the CD31 molecule in thrombotic risk through the formation of monocyte-platelet (Mo-Plt) aggregates in patients with ACS with no-ST...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cardiovascular medicine Vol. 8; p. 741221
Main Authors Vinci, Ramona, Pedicino, Daniela, Bonanni, Alice, d'Aiello, Alessia, Pisano, Eugenia, Ponzo, Myriana, Severino, Anna, Ciampi, Pellegrino, Canonico, Francesco, Russo, Giulio, Di Sario, Marianna, Vergallo, Rocco, Filomia, Simone, Montone, Rocco Antonio, Flego, Davide, Stefanini, Lucia, Piacentini, Roberto, Conte, Cristina, Cribari, Francesco, Massetti, Massimo, Crea, Filippo, Liuzzo, Giovanna
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 25.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the involvement of the CD31 molecule in thrombotic risk through the formation of monocyte-platelet (Mo-Plt) aggregates in patients with ACS with no-ST-segment elevation myocardial infarction (NSTEMI) on top of dual anti-platelet therapy (DAPT). We enrolled 19 control (CTRL) subjects, 46 stable angina (SA), and 86 patients with NSTEMI, of which, 16 with Intact Fibrous Cap (IFC) and 19 with Ruptured Fibrous Cap (RFC) as assessed by the Optical Coherence Tomography (OCT). The expression of CD31 on monocytes and platelets was measured. Following the coronary angiography, 52 NSTEMIs were further stratified according to thrombus grade (TG) evaluation. Finally, a series of ex vivo experiments verified whether the CD31 participates in Mo-Plt aggregate formation. In patients with NSTEMI, CD31 was reduced on monocytes and was increased on platelets, especially in NSTEMI presented with RFC plaques compared to those with IFC lesions, and in patients with high TG compared to those with zero/low TG. Ex vivo experiments documented an increase in Mo-Plt aggregates among NSTEMI, which significantly decreased after the CD31 ligation, particularly in patients with RFC plaques. In NSTEMI, CD31 participates in Mo-Plt aggregate formation in spite of optimal therapy and DAPT, suggesting the existence of alternative thrombotic pathways, as predominantly displayed in patients with RFC.
AbstractList Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the involvement of the CD31 molecule in thrombotic risk through the formation of monocyte-platelet (Mo-Plt) aggregates in patients with ACS with no-ST-segment elevation myocardial infarction (NSTEMI) on top of dual anti-platelet therapy (DAPT). We enrolled 19 control (CTRL) subjects, 46 stable angina (SA), and 86 patients with NSTEMI, of which, 16 with Intact Fibrous Cap (IFC) and 19 with Ruptured Fibrous Cap (RFC) as assessed by the Optical Coherence Tomography (OCT). The expression of CD31 on monocytes and platelets was measured. Following the coronary angiography, 52 NSTEMIs were further stratified according to thrombus grade (TG) evaluation. Finally, a series of ex vivo experiments verified whether the CD31 participates in Mo-Plt aggregate formation. In patients with NSTEMI, CD31 was reduced on monocytes and was increased on platelets, especially in NSTEMI presented with RFC plaques compared to those with IFC lesions, and in patients with high TG compared to those with zero/low TG. Ex vivo experiments documented an increase in Mo-Plt aggregates among NSTEMI, which significantly decreased after the CD31 ligation, particularly in patients with RFC plaques. In NSTEMI, CD31 participates in Mo-Plt aggregate formation in spite of optimal therapy and DAPT, suggesting the existence of alternative thrombotic pathways, as predominantly displayed in patients with RFC.
Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the involvement of the CD31 molecule in thrombotic risk through the formation of monocyte-platelet (Mo-Plt) aggregates in patients with ACS with no-ST-segment elevation myocardial infarction (NSTEMI) on top of dual anti-platelet therapy (DAPT). We enrolled 19 control (CTRL) subjects, 46 stable angina (SA), and 86 patients with NSTEMI, of which, 16 with Intact Fibrous Cap (IFC) and 19 with Ruptured Fibrous Cap (RFC) as assessed by the Optical Coherence Tomography (OCT). The expression of CD31 on monocytes and platelets was measured. Following the coronary angiography, 52 NSTEMIs were further stratified according to thrombus grade (TG) evaluation. Finally, a series of experiments verified whether the CD31 participates in Mo-Plt aggregate formation. In patients with NSTEMI, CD31 was reduced on monocytes and was increased on platelets, especially in NSTEMI presented with RFC plaques compared to those with IFC lesions, and in patients with high TG compared to those with zero/low TG. experiments documented an increase in Mo-Plt aggregates among NSTEMI, which significantly decreased after the CD31 ligation, particularly in patients with RFC plaques. In NSTEMI, CD31 participates in Mo-Plt aggregate formation in spite of optimal therapy and DAPT, suggesting the existence of alternative thrombotic pathways, as predominantly displayed in patients with RFC.
Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the involvement of the CD31 molecule in thrombotic risk through the formation of monocyte-platelet (Mo-Plt) aggregates in patients with ACS with no-ST-segment elevation myocardial infarction (NSTEMI) on top of dual anti-platelet therapy (DAPT). We enrolled 19 control (CTRL) subjects, 46 stable angina (SA), and 86 patients with NSTEMI, of which, 16 with Intact Fibrous Cap (IFC) and 19 with Ruptured Fibrous Cap (RFC) as assessed by the Optical Coherence Tomography (OCT). The expression of CD31 on monocytes and platelets was measured. Following the coronary angiography, 52 NSTEMIs were further stratified according to thrombus grade (TG) evaluation. Finally, a series of ex vivo experiments verified whether the CD31 participates in Mo-Plt aggregate formation. In patients with NSTEMI, CD31 was reduced on monocytes and was increased on platelets, especially in NSTEMI presented with RFC plaques compared to those with IFC lesions, and in patients with high TG compared to those with zero/low TG. Ex vivo experiments documented an increase in Mo-Plt aggregates among NSTEMI, which significantly decreased after the CD31 ligation, particularly in patients with RFC plaques. In NSTEMI, CD31 participates in Mo-Plt aggregate formation in spite of optimal therapy and DAPT, suggesting the existence of alternative thrombotic pathways, as predominantly displayed in patients with RFC.
Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the involvement of the CD31 molecule in thrombotic risk through the formation of monocyte-platelet (Mo-Plt) aggregates in patients with ACS with no-ST-segment elevation myocardial infarction (NSTEMI) on top of dual anti-platelet therapy (DAPT). We enrolled 19 control (CTRL) subjects, 46 stable angina (SA), and 86 patients with NSTEMI, of which, 16 with Intact Fibrous Cap (IFC) and 19 with Ruptured Fibrous Cap (RFC) as assessed by the Optical Coherence Tomography (OCT). The expression of CD31 on monocytes and platelets was measured. Following the coronary angiography, 52 NSTEMIs were further stratified according to thrombus grade (TG) evaluation. Finally, a series of ex vivo experiments verified whether the CD31 participates in Mo-Plt aggregate formation. In patients with NSTEMI, CD31 was reduced on monocytes and was increased on platelets, especially in NSTEMI presented with RFC plaques compared to those with IFC lesions, and in patients with high TG compared to those with zero/low TG. Ex vivo experiments documented an increase in Mo-Plt aggregates among NSTEMI, which significantly decreased after the CD31 ligation, particularly in patients with RFC plaques. In NSTEMI, CD31 participates in Mo-Plt aggregate formation in spite of optimal therapy and DAPT, suggesting the existence of alternative thrombotic pathways, as predominantly displayed in patients with RFC.Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the involvement of the CD31 molecule in thrombotic risk through the formation of monocyte-platelet (Mo-Plt) aggregates in patients with ACS with no-ST-segment elevation myocardial infarction (NSTEMI) on top of dual anti-platelet therapy (DAPT). We enrolled 19 control (CTRL) subjects, 46 stable angina (SA), and 86 patients with NSTEMI, of which, 16 with Intact Fibrous Cap (IFC) and 19 with Ruptured Fibrous Cap (RFC) as assessed by the Optical Coherence Tomography (OCT). The expression of CD31 on monocytes and platelets was measured. Following the coronary angiography, 52 NSTEMIs were further stratified according to thrombus grade (TG) evaluation. Finally, a series of ex vivo experiments verified whether the CD31 participates in Mo-Plt aggregate formation. In patients with NSTEMI, CD31 was reduced on monocytes and was increased on platelets, especially in NSTEMI presented with RFC plaques compared to those with IFC lesions, and in patients with high TG compared to those with zero/low TG. Ex vivo experiments documented an increase in Mo-Plt aggregates among NSTEMI, which significantly decreased after the CD31 ligation, particularly in patients with RFC plaques. In NSTEMI, CD31 participates in Mo-Plt aggregate formation in spite of optimal therapy and DAPT, suggesting the existence of alternative thrombotic pathways, as predominantly displayed in patients with RFC.
Author Montone, Rocco Antonio
Bonanni, Alice
Severino, Anna
Liuzzo, Giovanna
Pedicino, Daniela
Flego, Davide
Vinci, Ramona
Filomia, Simone
d'Aiello, Alessia
Russo, Giulio
Crea, Filippo
Cribari, Francesco
Massetti, Massimo
Ciampi, Pellegrino
Canonico, Francesco
Pisano, Eugenia
Di Sario, Marianna
Piacentini, Roberto
Ponzo, Myriana
Vergallo, Rocco
Stefanini, Lucia
Conte, Cristina
AuthorAffiliation 2 Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome , Italy
1 Department of Cardiovascular and Pulmonary Sciences, Università Cattolica del Sacro Cuore , Rome , Italy
3 Department of Internal Medicine and Medical Specialties, Sapienza University of Rome , Rome , Italy
4 Department of Neuroscience, Università Cattolica del Sacro Cuore , Rome , Italy
5 Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome , Italy
AuthorAffiliation_xml – name: 1 Department of Cardiovascular and Pulmonary Sciences, Università Cattolica del Sacro Cuore , Rome , Italy
– name: 2 Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome , Italy
– name: 3 Department of Internal Medicine and Medical Specialties, Sapienza University of Rome , Rome , Italy
– name: 5 Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome , Italy
– name: 4 Department of Neuroscience, Università Cattolica del Sacro Cuore , Rome , Italy
Author_xml – sequence: 1
  givenname: Ramona
  surname: Vinci
  fullname: Vinci, Ramona
– sequence: 2
  givenname: Daniela
  surname: Pedicino
  fullname: Pedicino, Daniela
– sequence: 3
  givenname: Alice
  surname: Bonanni
  fullname: Bonanni, Alice
– sequence: 4
  givenname: Alessia
  surname: d'Aiello
  fullname: d'Aiello, Alessia
– sequence: 5
  givenname: Eugenia
  surname: Pisano
  fullname: Pisano, Eugenia
– sequence: 6
  givenname: Myriana
  surname: Ponzo
  fullname: Ponzo, Myriana
– sequence: 7
  givenname: Anna
  surname: Severino
  fullname: Severino, Anna
– sequence: 8
  givenname: Pellegrino
  surname: Ciampi
  fullname: Ciampi, Pellegrino
– sequence: 9
  givenname: Francesco
  surname: Canonico
  fullname: Canonico, Francesco
– sequence: 10
  givenname: Giulio
  surname: Russo
  fullname: Russo, Giulio
– sequence: 11
  givenname: Marianna
  surname: Di Sario
  fullname: Di Sario, Marianna
– sequence: 12
  givenname: Rocco
  surname: Vergallo
  fullname: Vergallo, Rocco
– sequence: 13
  givenname: Simone
  surname: Filomia
  fullname: Filomia, Simone
– sequence: 14
  givenname: Rocco Antonio
  surname: Montone
  fullname: Montone, Rocco Antonio
– sequence: 15
  givenname: Davide
  surname: Flego
  fullname: Flego, Davide
– sequence: 16
  givenname: Lucia
  surname: Stefanini
  fullname: Stefanini, Lucia
– sequence: 17
  givenname: Roberto
  surname: Piacentini
  fullname: Piacentini, Roberto
– sequence: 18
  givenname: Cristina
  surname: Conte
  fullname: Conte, Cristina
– sequence: 19
  givenname: Francesco
  surname: Cribari
  fullname: Cribari, Francesco
– sequence: 20
  givenname: Massimo
  surname: Massetti
  fullname: Massetti, Massimo
– sequence: 21
  givenname: Filippo
  surname: Crea
  fullname: Crea, Filippo
– sequence: 22
  givenname: Giovanna
  surname: Liuzzo
  fullname: Liuzzo, Giovanna
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35146002$$D View this record in MEDLINE/PubMed
BookMark eNp1ksFu1DAQhiNUREvpnRPykUsW24kTmwNStRRYqQsIFombNXEmwZXX3jpJpX0Fnhqn26IWiZPHv2e-3x7P8-zIB49Z9pLRRVFI9aYzN9sFp5wt6pJxzp5kJ5yrOqdC_Dx6EB9nZ8NwRSllopSiks-y40KwsqKUn2S_18EHsx8x_-pgRIcjOe_7iH3aDGQTbd9jxJY0e7J8XzCyDg7N5JBYTz4Hn3_fkAuHNzDa4Ml6HwzE1oIjK99BNLP6liyd9dbM4nbnUjCrwwxIltcTkm_TbpwivsieduAGPLtbT7MfHy42y0_55ZePq-X5ZW5KVo15J4xpO-SNAmibCnnFIL1GlByUrDsFkkpe0YZB15ZdqWqoawONKoxQrOSqOM1WB24b4Ervot1C3OsAVt8KIfYa4miNQ22qhsq2acrOsFLUNBnWikrGwAjeQJ1Y7w6s3dRssTXoxwjuEfTxibe_dB9utJScUcUS4PUdIIbUi2HUWzsYdA48hmnQvOKSK0HlfO9XD73-mtx_ZkqoDgkmhmGI2Gljx9tuJ2vrNKN6Hhw9D46eB0cfBicV0n8K79n_LfkDw5XIvA
CitedBy_id crossref_primary_10_1016_j_ijscr_2023_108948
crossref_primary_10_1093_eurheartj_ehad379
Cites_doi 10.1161/CIRCULATIONAHA.110.970079
10.1093/eurheartj/ehaa721
10.1016/j.jacc.2007.10.030
10.1083/jcb.152.1.65
10.1016/j.ijcard.2019.04.060
10.1083/jcb.200205049
10.3389/fimmu.2019.01731
10.3389/fcell.2021.753223
10.1093/eurheartj/ehv029
10.1093/ehjcvp/pvaa001
10.1093/eurheartj/ehx684
10.1016/j.ijcard.2018.08.101
10.4244/EIJY19M06_02
10.1016/j.jacc.2011.09.079
10.1074/jbc.M109.073106
10.1073/pnas.1011748107
10.1007/s00395-014-0448-3
10.4049/jimmunol.164.1.452
10.1161/STROKEAHA.107.484766
10.1161/ATVBAHA.112.300379
10.1038/s41598-019-49253-3
10.1084/jem.184.1.41
10.1136/jcp.2005.025742
10.2174/138161211798764771
10.1182/blood-2002-01-0027
10.1016/j.jacc.2018.11.048
10.1161/01.STR.27.4.709
10.1161/CIRCRESAHA.120.315935
10.1016/j.cardiores.2003.11.036
10.1093/cvr/cvz132
10.1093/eurheartj/ehp433
10.1126/science.1690453
10.1080/14756366.2021.1900159
10.1055/s-0038-1646488
10.1038/s41598-021-90941-w
10.1093/eurheartj/ehx638
10.1093/eurheartj/ehaa703
10.1016/j.thromres.2016.12.003
10.4049/jimmunol.157.3.1233
10.1016/j.jacc.2018.06.072
10.1002/cyto.a.20623
10.1038/nrcardio.2016.166
10.1093/eurheartj/ehab088
10.1016/j.jacc.2014.09.017
10.1016/j.jacc.2020.11.010
10.1073/pnas.1509627112
10.1084/jem.178.2.449
10.1172/JCI119129
10.1182/blood.V99.1.137
10.1161/hc3801.095588
10.1161/CIRCRESAHA.118.311098
10.1161/ATVBAHA.107.151456
10.1161/01.ATV.17.11.3154
10.1016/j.jcmg.2015.01.018
10.1093/eurheartj/ehz425
ContentType Journal Article
Copyright Copyright © 2022 Vinci, Pedicino, Bonanni, d'Aiello, Pisano, Ponzo, Severino, Ciampi, Canonico, Russo, Di Sario, Vergallo, Filomia, Montone, Flego, Stefanini, Piacentini, Conte, Cribari, Massetti, Crea and Liuzzo.
Copyright © 2022 Vinci, Pedicino, Bonanni, d'Aiello, Pisano, Ponzo, Severino, Ciampi, Canonico, Russo, Di Sario, Vergallo, Filomia, Montone, Flego, Stefanini, Piacentini, Conte, Cribari, Massetti, Crea and Liuzzo. 2022 Vinci, Pedicino, Bonanni, d'Aiello, Pisano, Ponzo, Severino, Ciampi, Canonico, Russo, Di Sario, Vergallo, Filomia, Montone, Flego, Stefanini, Piacentini, Conte, Cribari, Massetti, Crea and Liuzzo
Copyright_xml – notice: Copyright © 2022 Vinci, Pedicino, Bonanni, d'Aiello, Pisano, Ponzo, Severino, Ciampi, Canonico, Russo, Di Sario, Vergallo, Filomia, Montone, Flego, Stefanini, Piacentini, Conte, Cribari, Massetti, Crea and Liuzzo.
– notice: Copyright © 2022 Vinci, Pedicino, Bonanni, d'Aiello, Pisano, Ponzo, Severino, Ciampi, Canonico, Russo, Di Sario, Vergallo, Filomia, Montone, Flego, Stefanini, Piacentini, Conte, Cribari, Massetti, Crea and Liuzzo. 2022 Vinci, Pedicino, Bonanni, d'Aiello, Pisano, Ponzo, Severino, Ciampi, Canonico, Russo, Di Sario, Vergallo, Filomia, Montone, Flego, Stefanini, Piacentini, Conte, Cribari, Massetti, Crea and Liuzzo
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fcvm.2021.741221
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2297-055X
ExternalDocumentID oai_doaj_org_article_c6b08dbb4fc14570adb790811ac52ba7
PMC8821091
35146002
10_3389_fcvm_2021_741221
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAYXX
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
CITATION
GROUPED_DOAJ
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c416t-f5ccdfe2b9aadb6e261a146542a987f9a808260b1afd4f497a77cab93c5914293
IEDL.DBID M48
ISSN 2297-055X
IngestDate Wed Aug 27 01:25:25 EDT 2025
Thu Aug 21 18:45:30 EDT 2025
Fri Jul 11 06:53:18 EDT 2025
Thu Jan 02 22:54:58 EST 2025
Tue Jul 01 03:18:40 EDT 2025
Thu Apr 24 22:52:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords CD31
monocyte-platelet aggregates
thrombus burden
unstable plaque
plaque rupture
precision medicine
acute coronary syndromes
Language English
License Copyright © 2022 Vinci, Pedicino, Bonanni, d'Aiello, Pisano, Ponzo, Severino, Ciampi, Canonico, Russo, Di Sario, Vergallo, Filomia, Montone, Flego, Stefanini, Piacentini, Conte, Cribari, Massetti, Crea and Liuzzo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c416t-f5ccdfe2b9aadb6e261a146542a987f9a808260b1afd4f497a77cab93c5914293
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Daiju Fukuda, Tokushima University, Japan
This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine
These authors have contributed equally to this work and share first authorship
These authors have contributed equally to this work and share last authorship
Reviewed by: Kenichiro Otsuka, Massachusetts General Hospital, United States; Junnan Tang, First Affiliated Hospital of Zhengzhou University, China
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fcvm.2021.741221
PMID 35146002
PQID 2628295089
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_c6b08dbb4fc14570adb790811ac52ba7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8821091
proquest_miscellaneous_2628295089
pubmed_primary_35146002
crossref_citationtrail_10_3389_fcvm_2021_741221
crossref_primary_10_3389_fcvm_2021_741221
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-01-25
PublicationDateYYYYMMDD 2022-01-25
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-25
  day: 25
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in cardiovascular medicine
PublicationTitleAlternate Front Cardiovasc Med
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Gawaz (B7) 2004; 61
Zhao (B23) 2001; 152
Saia (B18) 2015; 8
Collet (B3) 2021; 42
Valgimigli (B4) 2018; 39
Metzelaar (B21) 1991; 66
Newman (B19) 1990; 247
Cheung (B25) 2015; 112
Meza (B53) 2017; 150
Pasterkamp (B54) 2017; 14
Angelini (B46) 2018; 39
Caligiuri (B57) 2020; 126
Caligiuri (B50) 2019; 115
Libby (B55) 2019; 124
Rival (B26) 1996; 157
Tearney (B40) 2012; 59
Wilkinson (B30) 2002; 100
Sakhuja (B8) 2010; 122
Vergallo (B42) 2019; 292
Cicmil (B32) 2002; 99
Harrison (B51) 2013; 33
Mitra (B6) 2006; 59
Osawa (B49) 2002; 158
Newman (B20) 1997; 99
Michelson (B9) 2001; 104
Fukumoto (B47) 2008; 51
Kitazume (B22) 2010; 285
Rosenblum (B34) 1994; 145
B43
Prager (B28) 1996; 184
Ruggio (B13) 2019; 276
Prati (B39) 2010; 31
Mezger (B11) 2019; 10
Bartosch (B52) 2021; 11
Wu (B36) 1997; 17
Roth (B1) 2020; 76
Vinci (B17) 2021; 9
Nakada (B24) 2000; 164
Groen (B48) 2007; 38
Lee (B44) 2008; 73
Muller (B27) 1993; 178
Knuuti (B38) 2020; 41
Woodfin (B31) 2007; 27
Amsterdam (B37) 2014; 64
Johnson (B41) 2019; 15
Liu (B10) 2019; 9
Leistner (B14) 2020; 41
Bona (B56) 2011; 17
Pedicino (B12) 2018; 72
Ma (B29) 2010; 107
Benenati (B5) 2021; 7
Niccoli (B45) 2015; 36
Costa (B2) 2019; 73
Flego (B33) 2014; 109
Rosenblum (B35) 1996; 27
Liuzzo (B15) 2020; 41
Vinci (B16) 2021; 36
References_xml – volume: 122
  start-page: 2349
  year: 2010
  ident: B8
  article-title: Residual thrombogenic substrate after rupture of a lipid-rich plaque: possible mechanism of acute stent thrombosis?
  publication-title: Circulation.
  doi: 10.1161/CIRCULATIONAHA.110.970079
– volume: 41
  start-page: 3561
  year: 2020
  ident: B15
  article-title: CD8 lymphocytes and plaque erosion: a new piece in the jigsaw
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehaa721
– volume: 51
  start-page: 645
  year: 2008
  ident: B47
  article-title: Localized elevation of shear stress is related to coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution
  publication-title: J Am Coll Cardiol.
  doi: 10.1016/j.jacc.2007.10.030
– volume: 152
  start-page: 65
  year: 2001
  ident: B23
  article-title: Newman PJ. Integrin activation by regulated dimerization and oligomerization of platelet endothelial cell adhesion molecule (PECAM)-1 from within the cell
  publication-title: J Cell Biol.
  doi: 10.1083/jcb.152.1.65
– volume: 292
  start-page: 25
  year: 2019
  ident: B42
  article-title: Dual quantitative coronary angiography accurately quantifies intracoronary thrombotic burden in patients with acute coronary syndrome: comparison with optical coherence tomography imaging
  publication-title: Int J Cardiol.
  doi: 10.1016/j.ijcard.2019.04.060
– volume: 158
  start-page: 773
  year: 2002
  ident: B49
  article-title: Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule?
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200205049
– volume: 10
  start-page: 1731
  year: 2019
  ident: B11
  article-title: Platelets and immune responses during thromboinflammation
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2019.01731
– volume: 9
  start-page: 753223
  year: 2021
  ident: B17
  article-title: A novel monocyte subset as a unique signature of atherosclerotic plaque rupture
  publication-title: Front Cell Dev Biol.
  doi: 10.3389/fcell.2021.753223
– volume: 36
  start-page: 1377
  year: 2015
  ident: B45
  article-title: Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehv029
– volume: 7
  start-page: 86
  year: 2021
  ident: B5
  article-title: Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials
  publication-title: Eur Heart J Cardiovasc Pharmacother.
  doi: 10.1093/ehjcvp/pvaa001
– volume: 39
  start-page: 1089
  year: 2018
  ident: B46
  article-title: Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehx684
– volume: 276
  start-page: 289
  year: 2019
  ident: B13
  article-title: Correlation between CD4+CD28null T lymphocytes, regulatory T cells and plaque rupture: an optical coherence tomography study in acute coronary syndromes
  publication-title: Int J Cardiol.
  doi: 10.1016/j.ijcard.2018.08.101
– volume: 15
  start-page: 434
  year: 2019
  ident: B41
  article-title: Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European association of percutaneous cardiovascular interventions
  publication-title: EuroIntervention.
  doi: 10.4244/EIJY19M06_02
– volume: 59
  start-page: 1662
  year: 2012
  ident: B40
  article-title: Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International working group for intravascular optical coherence tomography standardization and validation
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2011.09.079
– volume: 285
  start-page: 6515
  year: 2010
  ident: B22
  article-title: Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M109.073106
– volume: 107
  start-page: 19461
  year: 2010
  ident: B29
  article-title: Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance
  publication-title: Proc Natl Acad Sci USA.
  doi: 10.1073/pnas.1011748107
– volume: 109
  start-page: 448
  year: 2014
  ident: B33
  article-title: Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients
  publication-title: Basic Res Cardiol.
  doi: 10.1007/s00395-014-0448-3
– volume: 164
  start-page: 452
  year: 2000
  ident: B24
  article-title: Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment
  publication-title: J Immunol
  doi: 10.4049/jimmunol.164.1.452
– volume: 38
  start-page: 2379
  year: 2007
  ident: B48
  article-title: Plaque rupture in the carotid artery is localized at the high shear stress region: a case report
  publication-title: Stroke.
  doi: 10.1161/STROKEAHA.107.484766
– volume: 33
  start-page: 694
  year: 2013
  ident: B51
  article-title: The role of platelet-endothelial cell adhesion molecule-1 in atheroma formation varies depending on the site-specific hemodynamic environment
  publication-title: Arterioscler Thromb Vasc Biol.
  doi: 10.1161/ATVBAHA.112.300379
– volume: 9
  start-page: 13069
  year: 2019
  ident: B10
  article-title: Platelet-leukocyte aggregate is associated with adverse events after surgical intervention for rheumatic heart disease
  publication-title: Sci Rep.
  doi: 10.1038/s41598-019-49253-3
– volume: 184
  start-page: 41
  year: 1996
  ident: B28
  article-title: Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses
  publication-title: J Exp Med.
  doi: 10.1084/jem.184.1.41
– volume: 59
  start-page: 232
  year: 2006
  ident: B6
  article-title: In stent restenosis: bane of the stent era
  publication-title: J Clin Pathol.
  doi: 10.1136/jcp.2005.025742
– volume: 17
  start-page: 4172
  year: 2011
  ident: B56
  article-title: Anti-inflammatory treatment of acute coronary syndromes
  publication-title: Curr Pharm Des.
  doi: 10.2174/138161211798764771
– volume: 100
  start-page: 184
  year: 2002
  ident: B30
  article-title: Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease
  publication-title: Blood.
  doi: 10.1182/blood-2002-01-0027
– volume: 73
  start-page: 741
  year: 2019
  ident: B2
  article-title: Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting
  publication-title: J Am Coll Cardiol.
  doi: 10.1016/j.jacc.2018.11.048
– volume: 27
  start-page: 709
  year: 1996
  ident: B35
  article-title: Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo
  publication-title: Stroke.
  doi: 10.1161/01.STR.27.4.709
– volume: 126
  start-page: 1178
  year: 2020
  ident: B57
  article-title: CD31 as a therapeutic target in atherosclerosis
  publication-title: Circ Res.
  doi: 10.1161/CIRCRESAHA.120.315935
– volume: 61
  start-page: 498
  year: 2004
  ident: B7
  article-title: Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium
  publication-title: Cardiovasc Res.
  doi: 10.1016/j.cardiores.2003.11.036
– volume: 115
  start-page: 1425
  year: 2019
  ident: B50
  article-title: Mechanotransduction, immunoregulation, and metabolic functions of CD31 in cardiovascular pathophysiology
  publication-title: Cardiovasc Res.
  doi: 10.1093/cvr/cvz132
– volume: 31
  start-page: 401
  year: 2010
  ident: B39
  article-title: Mintz, GS, Arbustini E, Di Mario C, Jang IK, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehp433
– volume: 247
  start-page: 1219
  year: 1990
  ident: B19
  article-title: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily
  publication-title: Science.
  doi: 10.1126/science.1690453
– volume: 36
  start-page: 785
  year: 2021
  ident: B16
  article-title: Platelet hyaluronidase 2 enrichment in acute coronary syndromes: a conceivable role in monocyte-platelet aggregate formation
  publication-title: J Enzyme Inhib Med Chem.
  doi: 10.1080/14756366.2021.1900159
– ident: B43
– volume: 66
  start-page: 700
  year: 1991
  ident: B21
  article-title: Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets
  publication-title: Thromb Haemost.
  doi: 10.1055/s-0038-1646488
– volume: 11
  start-page: 11386
  year: 2021
  ident: B52
  article-title: Heparan sulfate proteoglycan glypican-1 and PECAM-1 cooperate in shear-induced endothelial nitric oxide production
  publication-title: Sci Rep.
  doi: 10.1038/s41598-021-90941-w
– volume: 39
  start-page: 213
  year: 2018
  ident: B4
  article-title: ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx638
– volume: 41
  start-page: 3549
  year: 2020
  ident: B14
  article-title: Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehaa703
– volume: 150
  start-page: 44
  year: 2017
  ident: B53
  article-title: Platelets modulate endothelial cell response to dynamic shear stress through PECAM-1
  publication-title: Thromb Res.
  doi: 10.1016/j.thromres.2016.12.003
– volume: 157
  start-page: 1233
  year: 1996
  ident: B26
  article-title: Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.157.3.1233
– volume: 72
  start-page: 1490
  year: 2018
  ident: B12
  article-title: Alterations of hyaluronan metabolism in acute coronary syndrome: implications for plaque erosion
  publication-title: J Am Coll Cardiol.
  doi: 10.1016/j.jacc.2018.06.072
– volume: 73
  start-page: 926
  year: 2008
  ident: B44
  article-title: MIFlowCyt: the minimum information about a flow cytometry experiment
  publication-title: Cytometry A.
  doi: 10.1002/cyto.a.20623
– volume: 14
  start-page: 21
  year: 2017
  ident: B54
  article-title: Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2016.166
– volume: 42
  start-page: 1289
  year: 2021
  ident: B3
  article-title: ESC scientific document group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehab088
– volume: 64
  start-page: e139
  year: 2014
  ident: B37
  article-title: 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2014.09.017
– volume: 76
  start-page: 2982
  year: 2020
  ident: B1
  article-title: Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study
  publication-title: J Am Coll Cardiol.
  doi: 10.1016/j.jacc.2020.11.010
– volume: 112
  start-page: E5815
  year: 2015
  ident: B25
  article-title: CD31 signals confer immune privilege to the vascular endothelium
  publication-title: Proc Natl Acad Sci USA.
  doi: 10.1073/pnas.1509627112
– volume: 178
  start-page: 449
  year: 1993
  ident: B27
  article-title: PECAM-1 is required for transendothelial migration of leukocytes
  publication-title: J Exp Med
  doi: 10.1084/jem.178.2.449
– volume: 99
  start-page: 3
  year: 1997
  ident: B20
  article-title: The biology of PECAM-1
  publication-title: J Clin Invest.
  doi: 10.1172/JCI119129
– volume: 99
  start-page: 137
  year: 2002
  ident: B32
  article-title: Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets
  publication-title: Blood.
  doi: 10.1182/blood.V99.1.137
– volume: 104
  start-page: 1533
  year: 2001
  ident: B9
  article-title: Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction
  publication-title: Circulation.
  doi: 10.1161/hc3801.095588
– volume: 124
  start-page: 150
  year: 2019
  ident: B55
  article-title: Reassessing the Mechanisms of Acute Coronary Syndromes
  publication-title: Circ Res.
  doi: 10.1161/CIRCRESAHA.118.311098
– volume: 27
  start-page: 2514
  year: 2007
  ident: B31
  article-title: PECAM-1: a multi-functional molecule in inflammation and vascular biology
  publication-title: Arterioscler Thromb Vasc Biol.
  doi: 10.1161/ATVBAHA.107.151456
– volume: 145
  start-page: 33
  year: 1994
  ident: B34
  article-title: Anti-CD31 delays platelet adhesion/aggregation at sites of endothelial injury in mouse cerebral arterioles
  publication-title: Am J Pathol.
– volume: 17
  start-page: 3154
  year: 1997
  ident: B36
  article-title: Binding properties and inhibition of platelet aggregation by a monoclonal antibody to CD31 (PECAM-1)
  publication-title: Arterioscler Thromb Vasc Biol.
  doi: 10.1161/01.ATV.17.11.3154
– volume: 8
  start-page: 566
  year: 2015
  ident: B18
  article-title: Eroded versus ruptured plaques at the culprit site of stemi: in vivo pathophysiological features and response to primary PCI
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2015.01.018
– volume: 41
  start-page: 407
  year: 2020
  ident: B38
  article-title: 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehz425
SSID ssj0001548568
Score 2.2004576
Snippet Despite the recent innovations in cardiovascular care, atherothrombosis is still a major complication of acute coronary syndromes (ACS). We evaluated the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 741221
SubjectTerms acute coronary syndromes
Cardiovascular Medicine
CD31
monocyte-platelet aggregates
plaque rupture
thrombus burden
unstable plaque
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDxUXBOUVHpWRuHAIG3tjO-bWllYFaSsEW6k3y57YbaVVtqK7SPsX-NXMxOlqFyG4cHWc2PHMeGY8nm8Ye6t0Gy3g7ie1RQclVOMyWGFLkVQKENqkerDqyZk-Pa8_X6iLjVJfdCcswwPnhRuBDlXThlAnELUylW-DsajHhAclg-_zyFHnbThTOT-4bpRuclwSvTA7SvCDEs-leI86VEqxpYd6uP4_2Zi_X5Xc0D0nD9mDwWjkB3myj9i92O2x3ckQFn_MfqJkzmG1iOWXGdqOSAp-cImONB2R3fIpOuCXVJKThxU_-jgWfJJr4kZ-3fGzeVd-m_LjWcyHs3yyQvVGbDPjn7qEckCtH_gAIIqNG3fQ6QM4JP4N_7q8oWDEE3Z-cjw9Oi2HIgsloC22KJMCaFOUwXpcWh3Ro_KCQNakt41J1jdoJOgqCJ_aOtXWeGPABzsGZQUqs_FTttPNu_ic8QqQLQNIq7GrMK2XIWqbFG4JyUCAgo3ultzBgEBOhTBmDj0RIpIjIjkikstEKti79Rs3GX3jL30PiYrrfoSb3TcgN7mBm9y_uKlgb-54wKGcUfDEd3G-vHVSU8wZzVlbsGeZJ9ZDUTYExTcLZra4ZWsu20-666seyxsdHIJmffE_Jv-S3ZeUnFGJUqpXbGfxfRlfo8m0CPu9dPwCwHEYOw
  priority: 102
  providerName: Directory of Open Access Journals
Title Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque Rupture
URI https://www.ncbi.nlm.nih.gov/pubmed/35146002
https://www.proquest.com/docview/2628295089
https://pubmed.ncbi.nlm.nih.gov/PMC8821091
https://doaj.org/article/c6b08dbb4fc14570adb790811ac52ba7
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkRAXxJtQqIzEhUPa2BvbMRJCpbQqSKkQ7Eq9WbZjL5WipOyjYv8Cv5qZJF26aMWJq-MkTmYm840n8w0hr4Wsgvbw9eNSQ4DislHqNNMpiyI676ooOrLq8kyeTvLP5-L8T3n08ALnW0M77Cc1mdX7P3-s3oPBv8OIE_ztQfRXWFPO2T64R45V5bfBLynsZ1AOYL-vGc4LIYs-V7n1xA3f1FH4b8Odf_8-ecMfndwn9wYgSQ97yT8gt0LzkNwph1T5I_ILrLX1q0VIv9SAJ0E89HAKwTVum83pGILyKbbppG5Fjz6OGC37PrmBXjT0rG3Sb2N6XId-w5aWK3B5qEo1_dREsA0cfUsHUlEYvPFfOl4AbglPQ78uLzFB8ZhMTo7HR6fp0Hgh9YDPFmkU3lcxcKetrZwMEGVZhsRr3OpCRW0LAA4yc8zGKo-5VlYpb50eeaEZOLjRE7LTtE14RmjmQVWd51rCVKYqy12QOgr4TETlnU_IwfUrN35gJcfmGLWB6ASFZFBIBoVkeiEl5M36jMuekeMfcz-gFNfzkEu7G2hnUzOYpvHSZUXlXB49y4XKYL1KA1Ji1gvurErIq2sdMGB7mFCxTWiXc8Ml5qEB4uqEPO11Yn0rrJDAnGdC1Ia2bKxl80hz8b3j94agB-lan_-Pxe-SuxwLNjKWcvGC7Cxmy_ASYNTC7XXbD3udjfwG-PEgwA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Monocyte-Platelet+Aggregates+Triggered+by+CD31+Molecule+in+Non-ST+Elevation+Myocardial+Infarction%3A+Clinical+Implications+in+Plaque+Rupture&rft.jtitle=Frontiers+in+cardiovascular+medicine&rft.au=Ramona+Vinci&rft.au=Ramona+Vinci&rft.au=Daniela+Pedicino&rft.au=Daniela+Pedicino&rft.date=2022-01-25&rft.pub=Frontiers+Media+S.A&rft.eissn=2297-055X&rft.volume=8&rft_id=info:doi/10.3389%2Ffcvm.2021.741221&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c6b08dbb4fc14570adb790811ac52ba7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2297-055X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2297-055X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2297-055X&client=summon